[1] 453 407
  Record.ID First.Author       Year Country..choice.Afghanistan. Country..choice.Aland.Islands.
1    473248         Naci 2013-01-01                    Unchecked                      Unchecked
2    473269          Lin 2014-01-01                    Unchecked                      Unchecked
3    473552     Valentin 2011-01-01                    Unchecked                      Unchecked
4    474842  Castellucci 2014-01-01                    Unchecked                      Unchecked
5    476033       Jansen 2009-01-01                    Unchecked                      Unchecked
6    476343      Edwards 2015-01-01                    Unchecked                      Unchecked
  Country..choice.Albania. Country..choice.Algeria. Country..choice.American.Samoa.
1                Unchecked                Unchecked                       Unchecked
2                Unchecked                Unchecked                       Unchecked
3                Unchecked                Unchecked                       Unchecked
4                Unchecked                Unchecked                       Unchecked
5                Unchecked                Unchecked                       Unchecked
6                Unchecked                Unchecked                       Unchecked
  Country..choice.Andorra. Country..choice.Angola.
1                Unchecked               Unchecked
2                Unchecked               Unchecked
3                Unchecked               Unchecked
4                Unchecked               Unchecked
5                Unchecked               Unchecked
6                Unchecked               Unchecked
[1] "getting dataset:" "473248"          
[1] "getting dataset:" "473269"          
Studies: | Treatments: | Type: binary | Effect: RR 
[1] "year"  "study" "id"    "t"     "r"     "n"    
  year   study id t   r   n
1 2002 Fellman  1 1  90 188
2   NA    <NA>  1 5 111 179
3 2001 Netland  2 3  96 193
4   NA    <NA>  2 5 108 197
5 2012   Chabi  3 1 173 312
6   NA    <NA>  3 4 178 298
[1] "getting dataset:" "473552"          
Studies: | Treatments: | Type: binary | Effect: OR 
 [1] "year"     "study"    "id"       "t"        "r"        "n"        "...7"     "...8"    
 [9] "Benefit"  "Outcome:" "ACR70"    "...12"   
  year           study id t   r   n ...7 ...8 Benefit  Outcome: ACR70                 ...12
1 2007 Nishimoto, 2007  1 9  52 158   NA   NA      NA      <NA>    NA                  <NA>
2   NA            <NA>  1 1   9 148   NA   NA      NA      <NA>    NA                  <NA>
3 2008    Smolen, 2008  2 9  71 419   NA   NA      NA Treatment    NA                  <NA>
4   NA            <NA>  2 1   4 204   NA   NA      NA      <NA>     1 Placebo/Standard Care
5 2008  Genovese, 2008  3 9 169 805   NA   NA      NA      <NA>     2             abatacept
6   NA            <NA>  3 1  12 415   NA   NA      NA      <NA>     3            adalimumab
[1] "getting dataset:" "474842"          
Studies: | Treatments: | Type: binary | Effect: OR 
 [1] "year"                                       "study"                                     
 [3] "id"                                         "t"                                         
 [5] "n"                                          "r"                                         
 [7] "...7"                                       "Harmful"                                   
 [9] "Outcome:"                                   "rates of recurrent venous  thromboembolism"
[11] "...11"                                      "Comment"                                   
  year                         study id t   n  r ...7 Harmful Outcome:
1 1991 Collaborative European Study,  1 1  81  2   NA      NA       NA
2   NA Collaborative European Study,  1 2  85  3   NA      NA       NA
3 1992                    Hull et al  2 1 219 15   NA      NA       NA
4   NA                    Hull et al  2 2 213  6   NA      NA       NA
5 1992                Lopaciuk et al  3 1  75  3   NA      NA       NA
6   NA                Lopaciuk et al  3 2  74  0   NA      NA       NA
  rates of recurrent venous  thromboembolism ...11                             Comment
1                                       <NA>    NA                                <NA>
2                                 Treatments     1          UFH + vitamin K antagonist
3                                       <NA>     2         LMWH + vitamin K antagonist
4                                       <NA>     3                          LMWH alone
5                                       <NA>     4 Fondaparinux + vitamin K antagonist
6                                       <NA>     5                         Rivaroxaban
[1] "getting dataset:" "476033"          
Studies: | Treatments: | Type: binary | Effect: OR 
 [1] "year"      "study"     "id"        "t"         "r"         "n"         "...7"      "Harm"     
 [9] "Outcome:"  "fractures" "...11"    
  year                 study id t   r    n ...7 Harm   Outcome: fractures           ...11
1 2007    Black et al., 2007  1 1 310 2853   NA   NA Treatments         1         placbeo
2   NA                  <NA>  1 2  92 2822   NA   NA       <NA>         2 zoledronic acid
3 2005  Chesnut et al., 2005  2 1  73  975   NA   NA       <NA>         3     ibandronate
4   NA                  <NA>  2 3  37  977   NA   NA       <NA>         4     alendronate
5 1995 Liberman et al., 1995  3 1  22  355   NA   NA       <NA>         5    risideronate
6   NA                  <NA>  3 4  17  526   NA   NA       <NA>        NA            <NA>
[1] "getting dataset:" "476343"          
Studies: | Treatments: | Type: survival | Effect: HR 
 [1] "Study year"                                                                  
 [2] "Study name"                                                                  
 [3] "id"                                                                          
 [4] "t1"                                                                          
 [5] "t2"                                                                          
 [6] "yHR"                                                                         
 [7] "effect"                                                                      
 [8] "CILhr"                                                                       
 [9] "CIHhr"                                                                       
[10] "CIL"                                                                         
[11] "CIH"                                                                         
[12] "seHR"                                                                        
[13] "se"                                                                          
[14] "Beneficial"                                                                  
[15] "Outcome: Overall survival in the platinum-sensitive recurrent ovarian cancer"
[16] "...16"                                                                       
[17] "...17"                                                                       
[18] "...18"                                                                       
  Study year           Study name id t1 t2  yHR      effect CILhr CIHhr        CIL         CIH
1       2008              Alberts  1  1  2 0.70 -0.35667494  0.40  1.21 -0.9162907  0.19062036
2       2010           Bafaloukos  2  1  3 1.15  0.13976194  0.78  1.66 -0.2484614  0.50681760
3       2003 ICON4/AGO-OVAR 2.261  3  3  4 0.82 -0.19845094  0.69  0.97 -0.3710637 -0.03045921
4       2012              CALYPSO  4  1  3 0.99 -0.01005034  0.85  1.16 -0.1625189  0.14842001
5       2005      Gonzalez-Martin  5  3  4 0.31 -1.17118298  0.14  0.68 -1.9661129 -0.38566248
6       2006            Pfisterer  6  5  4 0.96 -0.04082199  0.75  1.23 -0.2876821  0.20701417
        seHR         se Beneficial
1 0.20663265 0.28237528         NA
2 0.22448980 0.19267320         NA
3 0.07142857 0.08688890         NA
4 0.07908163 0.07932116         NA
5 0.13775510 0.40317612         NA
6 0.12244898 0.12619802         NA
  Outcome: Overall survival in the platinum-sensitive recurrent ovarian cancer      ...16 ...17
1                                                                           NA       <NA>    NA
2                                                                           NA Treatments     1
3                                                                           NA       <NA>     2
4                                                                           NA       <NA>     3
5                                                                           NA       <NA>     4
6                                                                           NA       <NA>     5
                            ...18
1                            <NA>
2              PLDH + carboplatin
3 Carboplatin alone every 4 weeks
4        Paclitaxel + carboplatin
5     Carboplatin alone every day
6    Gemcitabine plus carboplatin
[1] "getting dataset:" "479531"          
Studies: | Treatments: | Type: binary | Effect: OR 
[1] "year"  "study" "id"    "t"     "r"     "n"    
  year                    study id  t   r   n
1 2008   089 Study (Malan 2008)  1  1  71  95
2   NA   089 Study (Malan 2008)  1  2  73 105
3 2006 934 Study (Gallant 2006)  2 10 173 254
4   NA 934 Study (Gallant 2006)  2 12 196 255
5 2008       ALERT (Smith 2008)  4  4  44  53
6   NA       ALERT (Smith 2008)  4 15  40  53
[1] "getting dataset:" "479574"          
Studies: | Treatments: | Type: binary | Effect: OR 
 [1] "year"                     "study"                    "id"                      
 [4] "t"                        "r"                        "n"                       
 [7] "...7"                     "Harm"                     "Outcome:"                
[10] "target revascularization" "...11"                   
  year     study id t  r   n ...7 Harm   Outcome: target revascularization
1    ?    ACTION  1 2 49 241   NA   NA Treatments                        1
2 <NA>      <NA>  1 1 11 119   NA   NA       <NA>                        2
3 2003  FUTURE I  2 3  1  27   NA   NA       <NA>                        3
4 <NA>      <NA>  2 1  1  15   NA   NA       <NA>                        4
5 2004 FUTURE II  3 3  1  21   NA   NA       <NA>                        5
6 <NA>      <NA>  3 1  6  43   NA   NA       <NA>                        6
                                ...11
1                                 BMS
2           Actinomycin-eluting stent
3  Polymeric everolimus-eluting stent
4         Mycophenolate-eluting stent
5 Apolymeric paclitaxel-eluting stent
6  Polymeric paclitaxel-eluting stent
[1] "getting dataset:" "479585"          
Studies: | Treatments: | Type: binary | Effect: OR 
 [1] "year"                           "study"                         
 [3] "id"                             "t"                             
 [5] "n"                              "r"                             
 [7] "...7"                           "Harmful"                       
 [9] "Outcome:"                       "Number of total adverse events"
[11] "...11"                          "Comment"                       
   year    study id t   n   r ...7    Harmful Outcome:         Number of total adverse events ...11
1  2005 Genovese  1 1 133  95   NA       <NA>       NA                                   <NA>    NA
2  <NA> Genovese  1 2 258 205   NA Treatments        1 Control: any other therapy or placebo.    NA
3  2006   Kremer  2 1 219 184   NA       <NA>        2                              Abatacept    NA
4  <NA>   Kremer  2 2 433 378   NA       <NA>        3                             Adalimumab    NA
5 2008a   Schiff  3 1 110  92   NA       <NA>        4                               Anakinra    NA
6  <NA>   Schiff  3 2 156 129   NA       <NA>        5                           Certolizumab    NA
  Comment
1      NA
2      NA
3      NA
4      NA
5      NA
6      NA
[1] "getting dataset:" "479586"          
[1] "getting dataset:" "479600"          
Studies: | Treatments: | Type: binary | Effect: OR 
 [1] "year"       "study"      "id"         "t"          "n"          "r"          "...7"      
 [8] "Beneficial" "Outcome:"   "ACR 50"    
   year  study id t   n   r ...7 Beneficial Outcome:     ACR 50
1  2006 Kremer  1 1 424 169   NA       <NA>       NA       <NA>
2  <NA> Kremer  1 2 214  36   NA Treatments        1    Placebo
3  2003 Kremer  2 1 119  14   NA       <NA>        2  Abatacept
4  <NA> Kremer  2 2 115  42   NA       <NA>        3 Infliximab
5 2008a Schiff  3 1 156  63   NA       <NA>        4 Adalimumab
6  <NA> Schiff  3 2 110  22   NA       <NA>        5   Anakinra
[1] "getting dataset:" "479603"          
Studies: | Treatments: | Type: binary | Effect: OR 
 [1] "study year"                                           
 [2] "study name"                                           
 [3] "id"                                                   
 [4] "t"                                                    
 [5] "r"                                                    
 [6] "n"                                                    
 [7] "...7"                                                 
 [8] "BENEFICIAL"                                           
 [9] "Outcome: >50% reduction in monthly migraine frequency"
[10] "...10"                                                
  study year study name id t  r   n ...7 BENEFICIAL
1       1976    Diamond  1 1 17  83   NA       <NA>
2       <NA>       <NA>  1 2 34  83   NA Treatments
3       2009     Dodick  2 3 99 178   NA       <NA>
4       <NA>       <NA>  2 4 78 169   NA       <NA>
5       2007 de Tommaso  3 3  8  13   NA       <NA>
6       <NA>       <NA>  3 5  8  15   NA       <NA>
  Outcome: >50% reduction in monthly migraine frequency         ...10
1                                                    NA          <NA>
2                                                     1       Placebo
3                                                     2   Propranolol
4                                                     3    Topiramate
5                                                     4 Amitriptyline
6                                                     5 Levetiracetam
[1] "getting dataset:" "479615"          
[1] "getting dataset:" "479622"          
Studies: | Treatments: | Type: continuous | Effect: MD 
 [1] "Study year"                                                                   
 [2] "Study name"                                                                   
 [3] "id"                                                                           
 [4] "t"                                                                            
 [5] "y"                                                                            
 [6] "sd"                                                                           
 [7] "n"                                                                            
 [8] "...8"                                                                         
 [9] "Harmful (the less the score the better it is, the less pain the patients had)"
[10] "...10"                                                                        
[11] "Outcome: change in total symptom score in chronic prostatitis (NIH-CPSI)"     
  Study year    Study name id t    y   sd   n ...8
1       2004 Alexander [4]  1 2 20.2 12.2  45   NA
2         NA          <NA>  1 3 18.0 13.2  42   NA
3         NA          <NA>  1 4 21.3 11.9  42   NA
4         NA          <NA>  1 1 21.6  9.8  45   NA
5       2008    Nickel [5]  2 2 16.7 14.9 138   NA
6         NA          <NA>  2 1 18.6 14.1 134   NA
  Harmful (the less the score the better it is, the less pain the patients had) ...10
1                                                                    Treatments     1
2                                                                          <NA>     2
3                                                                          <NA>     3
4                                                                          <NA>     4
5                                                                          <NA>     5
6                                                                          <NA>    NA
  Outcome: change in total symptom score in chronic prostatitis (NIH-CPSI)
1                                                                  Placebo
2                                                               α-Blockers
3                                                              Antibiotics
4                                                 α-Blockers + Antibiotics
5                                                        Anti-inflammatory
6                                                                     <NA>
[1] "getting dataset:" "479629"          
Studies: | Treatments: | Type: continuous | Effect: MD 
 [1] "study year" "study"      "id"         "t"          "y"          "sd"         "n"         
 [8] "...8"       "...9"       "...10"      "...11"      "...12"      "...13"      "...14"     
[15] "...15"     
  study year        study id t    y    sd  n ...8 ...9 ...10 ...11 ...12      ...13
1       2001 Buljina 2001 25 6 70.0 19.04 50   NA   NA    NA    NA    NA       Harm
2         NA         <NA> 25 7 32.4 14.78 50   NA   NA    NA    NA    NA Treatments
3       2007 Fransen 2007 26 6 40.0 16.20 41   NA   NA    NA    NA    NA       <NA>
4         NA         <NA> 26 7 27.3 18.70 55   NA   NA    NA    NA    NA       <NA>
5       2008     Jan 2008 27 6 35.5 17.00 30   NA   NA    NA    NA    NA       <NA>
6         NA         <NA> 27 7 24.0 17.50 34   NA   NA    NA    NA    NA       <NA>
                                                                            ...14            ...15
1 Outcome: pain intensity (0-100 scale; WMD between treatment and placebo groups)             <NA>
2                                                                               1          placebo
3                                                                               2 WHO 1 non opioid
4                                                                               3   WHO II opioids
5                                                                               4  WHO III opioids
6                                                                               5               AC
[1] "getting dataset:" "479647"          
[1] "getting dataset:" "479650"          
Studies: | Treatments: | Type: binary | Effect: OR 
 [1] "study"               "id"                  "t"                   "n"                  
 [5] "r"                   "...6"                "Harmful"             "Outcome:"           
 [9] "incidence of Cancer" "...10"               "Comment"            
              study id t   n  r ...6    Harmful Outcome: incidence of Cancer ...10 Comment
1             HSCSG  1 1 219  4   NA       <NA>       NA                <NA>    NA      NA
2             HSCSG  1 2 233  4   NA Treatments        1     placebo/Control    NA      NA
3 Coope & Warrender  2 1 465 23   NA       <NA>        2            Diuretic    NA      NA
4 Coope & Warrender  2 3 419 29   NA       <NA>        3        Beta-Blocker    NA      NA
5             EWPHE  3 1 424 22   NA       <NA>        4                ACEI    NA      NA
6             EWPHE  3 2 416 20   NA       <NA>        5                 CCB    NA      NA
[1] "getting dataset:" "479652"          
Studies: | Treatments: | Type: continuous | Effect: MD 
 [1] "Study year"                                                                   
 [2] "Study name"                                                                   
 [3] "id"                                                                           
 [4] "t"                                                                            
 [5] "y"                                                                            
 [6] "sd"                                                                           
 [7] "n"                                                                            
 [8] "...8"                                                                         
 [9] "Harmful (the less the score the better it is, the less pain the patients had)"
[10] "...10"                                                                        
[11] "Outcome: duration of diarrhea"                                                
  Study year         Study name id t    y   sd  n ...8
1       1988      Lolekha (THA)  1 1 81.3 64.5 14   NA
2       <NA>               <NA>  1 2 48.1 12.6 18   NA
3       <NA>               <NA>  1 7 54.3 15.5 15   NA
4       1990 Bhattacharya (IND)  2 1 29.3  4.5 12   NA
5       <NA>               <NA>  2 2 19.2  4.4 13   NA
6      1996a        Dutta (IND)  3 1 55.0 24.0 29   NA
  Harmful (the less the score the better it is, the less pain the patients had) ...10
1                                                                          <NA>    NA
2                                                                    Treatments     1
3                                                                          <NA>     2
4                                                                          <NA>     3
5                                                                          <NA>     4
6                                                                          <NA>     5
  Outcome: duration of diarrhea
1                          <NA>
2          Placebo/no treatment
3                   Norfloxacin
4                 Ciprofloxacin
5                  Tetracycline
6                   Doxycycline
[1] "getting dataset:" "479657"          
[1] "getting dataset:" "479661"          
Studies: | Treatments: | Type: binary | Effect: OR 
 [1] "year"               "study"              "id"                 "t"                 
 [5] "n"                  "r"                  "...7"               "Harmful"           
 [9] "Outcome:"           "incidence of stoke" "...11"              "Comment"           
  year   study id t   n  r ...7    Harmful Outcome: incidence of stoke ...11 Comment
1 1989 AFASK I  1 1 336 19   NA       <NA>       NA               <NA>    NA      NA
2   NA AFASK I  1 2 335  9   NA Treatments        1            Control    NA      NA
3   NA AFASK I  1 4 336 16   NA       <NA>        2           Warfarin    NA      NA
4 1990  BAATAF  2 1 208 13   NA       <NA>        3         Aspirin HD    NA      NA
5   NA  BAATAF  2 2 212  3   NA       <NA>        4         Aspirin LD    NA      NA
6 1991    CAFA  3 1 191  9   NA       <NA>       NA               <NA>    NA      NA
 [1] 473269 473552 474842 476033 476343 479531 479574 479585 479600 479603 479622 479629 479650
[14] 479652 479661
[1] "getting dataset:" "473269"          
[1] "getting dataset:" "473552"          
[1] "getting dataset:" "474842"          
[1] "getting dataset:" "476033"          
[1] "getting dataset:" "476343"          
[1] "getting dataset:" "479531"          
[1] "getting dataset:" "479574"          
[1] "getting dataset:" "479585"          
[1] "getting dataset:" "479600"          
[1] "getting dataset:" "479603"          
[1] "getting dataset:" "479622"          
[1] "getting dataset:" "479629"          
[1] "getting dataset:" "479650"          
[1] "getting dataset:" "479652"          
[1] "getting dataset:" "479661"          
# A tibble: 15 × 4
       id type       effect cols                                                                     
    <int> <chr>      <chr>  <chr>                                                                    
 1 473269 binary     RR     year, study, id, t, r, n                                                 
 2 473552 binary     OR     year, study, id, t, r, n, ...7, ...8, Benefit, Outcome:, ACR70, ...12    
 3 474842 binary     OR     year, study, id, t, n, r, ...7, Harmful, Outcome:, rates of recurrent ve…
 4 476033 binary     OR     year, study, id, t, r, n, ...7, Harm, Outcome:, fractures, ...11         
 5 476343 survival   HR     Study year, Study name, id, t1, t2, yHR, effect, CILhr, CIHhr, CIL, CIH,…
 6 479531 binary     OR     year, study, id, t, r, n                                                 
 7 479574 binary     OR     year, study, id, t, r, n, ...7, Harm, Outcome:, target revascularization…
 8 479585 binary     OR     year, study, id, t, n, r, ...7, Harmful, Outcome:, Number of total adver…
 9 479600 binary     OR     year, study, id, t, n, r, ...7, Beneficial, Outcome:, ACR 50             
10 479603 binary     OR     study year, study name, id, t, r, n, ...7, BENEFICIAL, Outcome: >50% red…
11 479622 continuous MD     Study year, Study name, id, t, y, sd, n, ...8, Harmful (the less the sco…
12 479629 continuous MD     study year, study, id, t, y, sd, n, ...8, ...9, ...10, ...11, ...12, ...…
13 479650 binary     OR     study, id, t, n, r, ...6, Harmful, Outcome:, incidence of Cancer, ...10,…
14 479652 continuous MD     Study year, Study name, id, t, y, sd, n, ...8, Harmful (the less the sco…
15 479661 binary     OR     year, study, id, t, n, r, ...7, Harmful, Outcome:, incidence of stoke, .…
[1] "getting dataset:" "473269"          
[1] "getting dataset:" "473552"          
[1] "getting dataset:" "474842"          
[1] "getting dataset:" "476033"          
[1] "getting dataset:" "476343"          
[1] "getting dataset:" "479531"          
[1] "getting dataset:" "479574"          
[1] "getting dataset:" "479585"          
[1] "getting dataset:" "479600"          
[1] "getting dataset:" "479603"          
[1] "getting dataset:" "479622"          
[1] "getting dataset:" "479629"          
[1] "getting dataset:" "479650"          
[1] "getting dataset:" "479652"          
[1] "getting dataset:" "479661"          
[[1]]
[1] "datasets/NMA_473269.xlsx"

[[2]]
[1] "datasets/NMA_473552.xlsx"

[[3]]
[1] "datasets/NMA_474842.xlsx"

[[4]]
[1] "datasets/NMA_476033.xlsx"

[[5]]
[1] "datasets/NMA_476343.xlsx"

[[6]]
[1] "datasets/NMA_479531.xlsx"

[[7]]
[1] "datasets/NMA_479574.xlsx"

[[8]]
[1] "datasets/NMA_479585.xlsx"

[[9]]
[1] "datasets/NMA_479600.xlsx"

[[10]]
[1] "datasets/NMA_479603.xlsx"

[[11]]
[1] "datasets/NMA_479622.xlsx"

[[12]]
[1] "datasets/NMA_479629.xlsx"

[[13]]
[1] "datasets/NMA_479650.xlsx"

[[14]]
[1] "datasets/NMA_479652.xlsx"

[[15]]
[1] "datasets/NMA_479661.xlsx"

